News
Urological cancers affect the organs that produce and pass urine, along with parts of the male reproductive system. and ...
Urinary tract infections are common in women, but frequent episodes could pose more than temporary discomfort. Uncover how ...
One of the most effective ways to prevent recurrent UTIs in postmenopausal women is vaginal estrogen therapy, which delivers ...
The main culprit for increased UTIs in menopausal women is the drop in estrogen levels. Estrogen plays a crucial role in ...
Bowl of Quick Cook on MSN6d
That Bump? It Could Be More Than a Pimple—Here’s Why You Need to Get It Checked OutYou look in the mirror and see a spot. It wasn’t there just yesterday, maybe. Sometimes we poke or try to squeeze it. But ...
Bladder cancer can be a silent killer, often presenting few symptoms in its early stages. Learn about the disease, its early symptoms, and more.
EAU guidelines offer updated guidance on diagnosis, treatment, & follow-up of patients with metastatic & muscle-invasive ...
6d
AZoNano on MSNNovel Nanoplatform Overcomes Treatment Resistance in Bladder CancerA breakthrough in bladder cancer treatment at the University of California, Davis: multifunctional nanoparticles enhance ...
6d
Verywell Health on MSNCan Tailbone Pain Be a Cancer Symptom? - MSNOvarian cancer: Lower back pain can be a sign of ovarian cancer. The pain can occur as discomfort that you feel consistently ...
Don’t wait until it’s too late. This Men’s Health Month, discover why open conversations about prostate cancer screening are ...
The new data comes shortly after Imfinzi was approved as a peri-operative treatment for muscle-invasive bladder cancer (MIBC), based on the results of the NIAGARA trial, which marked a return to ...
AstraZeneca has revealed the data for Imfinzi in muscle-invasive bladder cancer (MIBC) that it hopes will be enough to secure FDA approval – although the jury is out on that.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results